Year: 2011
Type: editorial
Abstract: The promise of chemoprophylaxis for tuberculosis has yet to be fully realized. Until recently, testing for and treating latent tuberculosis infection have been limited largely to low-burden settings, where active tuberculosis has been under good control. In the United States and several other low-burden countries, treatment of latent tuberculosis infection has been an alternative prevention strategy to early childhood immunization with bacille Calmette–Guerin (BCG). In high-burden settings, vaccination and the treatment of patients with positive smears have been the main public health strategies, with chemoprophylaxis recommended primarily for childhood contacts of patients with active tuberculosis, albeit it has been administered . . .
Source: New England Journal of Medicine
DOI: 10.1056/nejme1105555
Authors: Edward Nardell, Gavin Churchyard
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2002115975